Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2017 08:00 ET | Source: Neovacs

Neovacs to collaborate with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal cancer and ovarian cancer

PARIS and BOSTON, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV) a leader in active immunotherapies for the treatment of autoimmune diseases, today announced its collaboration...
January 05, 2017 01:00 ET | Source: NEOVACS

NEOVACS signe un partenariat avec le SUNNYBROOK INSTITUTE de Toronto, au Canada pour le développement préclinique du VEGF Kinoïde dans le cancer colorectal et le cancer des ovaires

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...
January 05, 2017 01:00 ET | Source: NEOVACS

NEOVACS to collaborate with the SUNNYBROOK RESEARCH INSTITUTE for preclinical development of VEGF Kinoid to treat colorectal cancer and ovarian cancer

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE· PRESS RELEASE· PRESS...
December 07, 2016 01:00 ET | Source: NEOVACS

NEOVACS obtains FDA "Fast Track" designation for IFNalpha Kinoid in Lupus (SLE)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE· PRESS RELEASE· PRESS...
December 07, 2016 01:00 ET | Source: NEOVACS

NEOVACS obtient la désignation « Fast-Track » par la FDA, pour l'IFNalpha Kinoïde dans le traitement du Lupus (LES)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
November 23, 2016 11:45 ET | Source: NEOVACS

Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
November 23, 2016 11:45 ET | Source: NEOVACS

Néovacs signe un partenariat avec 3P Biopharmaceuticals, leader espagnol dans la production de médicaments biologiques

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
November 15, 2016 01:00 ET | Source: NEOVACS

Néovacs acquiert la technologie de fabrication de l'interféron alpha auprès d'AMEGABIOTECH

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
November 15, 2016 01:00 ET | Source: NEOVACS

Neovacs acquires interferon alpha manufacturing technology from AMEGABIOTECH

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
November 07, 2016 01:00 ET | Source: NEOVACS

Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE· PRESS RELEASE· PRESS...